Results 171 to 180 of about 67,765 (240)

Antibiotic Use in Surgical Wards: A Point Prevalence Survey Based on the WHO AWaRe Methodology. [PDF]

open access: yesAntibiotics (Basel)
Dolcini J   +14 more
europepmc   +1 more source

Impact of varicocoelectomy on male semen parameters: A long‐term analysis of sperm quality and outcomes

open access: yesAndrology, Volume 14, Issue 2, Page 352-357, February 2026.
Abstract Background Varicocoeles are common in 40% of men presenting with infertility. Semen parameters including sperm motility, low sperm count and sperm morphology are altered by the presence of varicocoeles. Though varicocoelectomy has been associated with improvements in these parameters, studies on long‐term outcomes are limited.
Max D. Sandler   +6 more
wiley   +1 more source

Safety and efficacy of tranexamic acid in radical cystectomy: a systematic review and meta-analysis. [PDF]

open access: yesCent European J Urol
Costa de Sousa FR   +9 more
europepmc   +1 more source

Patient‐reported outcome measures in prostate research: a scoping review

open access: yesBJU International, Volume 137, Issue 2, Page 241-250, February 2026.
Objectives To summarise how patient‐reported outcome measures (PROMs) are used in prostate research, specifically in the 10 years after the 2010 CONsolidated Standards Of Reporting Trials (CONSORT) guidelines were introduced. Methods The search was focussed on randomised controlled trials (RCTs) reporting in the top 15 journals in oncology, urology ...
Grace J. Young   +6 more
wiley   +1 more source

Intravenous Lidocaine for Postoperative Pain and Recovery After Robotic Prostate Adenomectomy: A Retrospective Observational Cohort Study. [PDF]

open access: yesMedicina (Kaunas)
Popa GM   +10 more
europepmc   +1 more source

Long‐term outcomes of a cascading salvage strategy for high‐risk non‐muscle‐invasive bladder cancer

open access: yesBJU International, Volume 137, Issue 2, Page 339-347, February 2026.
Objective To report long‐term oncological outcomes of patients with high‐risk non‐muscle‐invasive bladder cancer (HR‐NMIBC) undergoing bladder‐sparing therapy (BST) after bacillus Calmette–Guérin (BCG) failure. Patients and Methods We retrospectively reviewed patients with HR‐NMIBC treated from 2000 to 2025 with intravesical therapies after BCG failure,
Ian M. McElree   +5 more
wiley   +1 more source

First Brazilian Series of Urologic Surgeries Using Versius Robotic Multiport Platform. [PDF]

open access: yesInt Braz J Urol
Almeida GL   +19 more
europepmc   +1 more source

Drug‐releasing intravesical floating technology for sequential gemcitabine and docetaxel in non‐muscle‐invasive bladder cancer

open access: yesBJU International, Volume 137, Issue 2, Page 360-367, February 2026.
Objectives To develop a drug‐releasing intravesical floating technology (DRIFT) device for controlled sequential delivery of gemcitabine and docetaxel (Gem/Doce) to optimise the treatment of non‐muscle‐invasive bladder cancer (NMIBC) while enabling patient mobility and self‐removal, as sequential intravesical Gem/Doce has been increasingly utilised but
Ashley C. Rhodes   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy